Callan Jmb Posts Wider Loss in Fiscal Q2
Callan Jmb (NASDAQ:CJMB), a provider of temperature-controlled logistics and emergency preparedness services for healthcare and life sciences, reported its second quarter fiscal 2025 results on August 14, 2025. A more severe net loss of $1.40 million (GAAP), compared to a $0.11 million (GAAP) loss in Q2 2024 was reported, as the company faced lower demand for its core emergency preparedness services. The company described the period as transitional, emphasizing investments in leadership, international presence, and new market partnerships, but made it clear that these efforts have not yet reversed negative trends in its core business.
Callan Jmb specializes in temperature-controlled supply chain and logistics services, mainly supporting the life sciences, pharmaceutical, and emergency preparedness sectors.
Recently, the company has aimed to diversify its business beyond emergency preparedness.
Source Fool.com
